Exagen Inc. to Participate in the Canaccord Genuity 43rd Annual Growth Conference
July 26, 2023 16:05 ET
|
Exagen Inc.
SAN DIEGO, July 26, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in the Canaccord Genuity 43rd Annual...